Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2021 | Apr. 30, 2021 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2021 | |
Document Transition Report | false | |
Entity File Number | 001-37935 | |
Entity Registrant Name | Acushnet Holdings Corp. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 45-2644353 | |
Entity Address, Address Line One | 333 Bridge Street | |
Entity Address, City or Town | Fairhaven, | |
Entity Address, State or Province | MA | |
Entity Address, Postal Zip Code | 02719 | |
City Area Code | 800 | |
Local Phone Number | 225-8500 | |
Title of 12(b) Security | Common Stock - $0.001 par value per share | |
Trading Symbol | GOLF | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 74,063,851 | |
Entity Central Index Key | 0001672013 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Current assets | ||
Cash, cash equivalents and restricted cash ($8,666 and $6,843 attributable to the variable interest entity ("VIE")) | $ 113,047 | $ 151,452 |
Accounts receivable, net | 387,507 | 201,518 |
Inventories ($11,046 and $13,830 attributable to the VIE) | 330,165 | 357,682 |
Prepaid and other assets | 92,343 | 89,155 |
Total current assets | 923,062 | 799,807 |
Property, plant and equipment, net ($10,319 and $10,538 attributable to the VIE) | 220,616 | 222,811 |
Goodwill ($32,312 and $32,312 attributable to the VIE) | 213,555 | 215,186 |
Intangible assets, net | 471,394 | 473,533 |
Deferred income taxes | 66,697 | 80,060 |
Other assets ($2,220 and $2,239 attributable to the VIE) | 73,558 | 75,158 |
Total assets | 1,968,882 | 1,866,555 |
Current liabilities | ||
Short-term debt | 24,696 | 2,810 |
Current portion of long-term debt | 17,500 | 17,500 |
Accounts payable ($5,714 and $8,702 attributable to the VIE) | 125,865 | 112,867 |
Accrued taxes | 54,575 | 40,952 |
Accrued compensation and benefits ($852 and $1,454 attributable to the VIE) | 67,693 | 82,290 |
Accrued expenses and other liabilities ($3,467 and $3,699 attributable to the VIE) | 108,468 | 101,260 |
Total current liabilities | 398,797 | 357,679 |
Long-term debt | 309,524 | 313,619 |
Deferred income taxes | 3,797 | 3,821 |
Accrued pension and other postretirement benefits | 121,811 | 121,929 |
Other noncurrent liabilities ($2,276 and $2,261 attributable to the VIE) | 48,876 | 52,128 |
Total liabilities | 882,805 | 849,176 |
Commitments and contingencies (Note 15) | ||
Redeemable noncontrolling interest | 97 | 126 |
Shareholders' equity | ||
Common stock, $0.001 par value, 500,000,000 shares authorized; 75,847,208 and 75,666,367 shares issued | 76 | 76 |
Additional paid-in capital | 926,809 | 925,385 |
Accumulated other comprehensive loss, net of tax | (98,160) | (96,182) |
Retained earnings | 271,967 | 199,776 |
Treasury stock, at cost; 1,783,357 and 1,671,754 shares (including 355,341 and 299,894 of accrued share repurchases) (Note 10) | (49,830) | (45,106) |
Total equity attributable to Acushnet Holdings Corp. | 1,050,862 | 983,949 |
Noncontrolling interests | 35,118 | 33,304 |
Total shareholders' equity | 1,085,980 | 1,017,253 |
Total liabilities, redeemable noncontrolling interest and shareholders' equity | $ 1,968,882 | $ 1,866,555 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Cash and restricted cash | $ 113,047 | $ 151,452 |
Inventories | 330,165 | 357,682 |
Property, plant and equipment, net | 220,616 | 222,811 |
Goodwill | 213,555 | 215,186 |
Other assets | 73,558 | 75,158 |
Accounts payable | 125,865 | 112,867 |
Accrued compensation and benefits | 67,693 | 82,290 |
Accrued expenses and other liabilities | 108,468 | 101,260 |
Other noncurrent liabilities | $ 48,876 | $ 52,128 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 75,847,208 | 75,666,367 |
Treasury stock, at cost (in shares) | 1,783,357 | 1,671,754 |
Accrued share repurchase (in shares) | 355,341 | 299,894 |
VIE | ||
Cash and restricted cash | $ 8,666 | $ 6,843 |
Inventories | 11,046 | 13,830 |
Property, plant and equipment, net | 10,319 | 10,538 |
Goodwill | 32,312 | 32,312 |
Other assets | 2,220 | 2,239 |
Accounts payable | 5,714 | 8,702 |
Accrued compensation and benefits | 852 | 1,454 |
Accrued expenses and other liabilities | 3,467 | 3,699 |
Other noncurrent liabilities | $ 2,276 | $ 2,261 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Income Statement [Abstract] | ||
Net sales | $ 580,885 | $ 408,741 |
Cost of goods sold | 270,146 | 207,786 |
Gross profit | 310,739 | 200,955 |
Operating expenses: | ||
Selling, general and administrative | 176,369 | 152,723 |
Research and development | 12,329 | 13,220 |
Intangible amortization | 1,972 | 1,956 |
Restructuring charges | 0 | 11,628 |
Income from operations | 120,069 | 21,428 |
Interest expense, net | 3,616 | 4,123 |
Other expense, net | 1,992 | 690 |
Income before income taxes | 114,461 | 16,615 |
Income tax expense | 27,834 | 7,640 |
Net income | 86,627 | 8,975 |
Less: Net income attributable to noncontrolling interests | (1,669) | (98) |
Net income attributable to Acushnet Holdings Corp. | $ 84,958 | $ 8,877 |
Net income per common share attributable to Acushnet Holdings Corp.: | ||
Basic (in dollars per share) | $ 1.14 | $ 0.12 |
Diluted (in dollars per share) | $ 1.13 | $ 0.12 |
Weighted average number of common shares: | ||
Basic (in shares) | 74,778,189 | 74,545,280 |
Diluted (in shares) | 75,255,312 | 75,099,930 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 86,627 | $ 8,975 |
Other comprehensive income (loss): | ||
Foreign currency translation adjustments | (7,080) | (22,783) |
Cash flow derivative instruments: | ||
Unrealized holding gains arising during period | 4,367 | 7,402 |
Reclassification adjustments included in net income | 563 | (1,724) |
Tax expense | (1,664) | (1,848) |
Cash flow derivative instruments, net | 3,266 | 3,830 |
Pension and other postretirement benefits: | ||
Pension and other postretirement benefits adjustments | 2,575 | 1,690 |
Tax expense | (739) | (368) |
Pension and other postretirement benefits adjustments, net | 1,836 | 1,322 |
Total other comprehensive loss | (1,978) | (17,631) |
Comprehensive income (loss) | 84,649 | (8,656) |
Less: Comprehensive income attributable to noncontrolling interests | (1,529) | (118) |
Comprehensive income (loss) attributable to Acushnet Holdings Corp. | $ 83,120 | $ (8,774) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Cash flows from operating activities | ||
Net income | $ 86,627 | $ 8,975 |
Adjustments to reconcile net income to cash flows used in operating activities | ||
Depreciation and amortization | 10,363 | 10,269 |
Unrealized foreign exchange gains | (3,593) | (200) |
Amortization of debt issuance costs | 917 | 213 |
Share-based compensation | 5,533 | 2,187 |
Loss (gain) on disposals of property, plant and equipment | 155 | (2) |
Deferred income taxes | 10,265 | (1,194) |
Changes in operating assets and liabilities | ||
Accounts receivable | (190,019) | (102,181) |
Inventories | 24,987 | 19,092 |
Accounts payable | 13,788 | (2,652) |
Accrued taxes | 15,039 | (2,125) |
Other assets and liabilities | (4,058) | (4,894) |
Cash flows used in operating activities | (29,996) | (72,512) |
Cash flows from investing activities | ||
Additions to property, plant and equipment | (6,410) | (5,741) |
Cash flows used in investing activities | (6,410) | (5,741) |
Cash flows from financing activities | ||
Proceeds from short-term borrowings, net | 22,178 | 125,133 |
Repayments of term loan facility | (4,375) | (4,375) |
Purchases of common stock | (2,377) | (6,976) |
Debt issuance costs | 0 | (14) |
Dividends paid on common stock | (12,658) | (11,521) |
Dividends paid to noncontrolling interests | (48) | 0 |
Payment of employee restricted stock tax withholdings | (3,946) | (380) |
Cash flows (used in) provided by financing activities | (1,226) | 101,867 |
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | (773) | (1,874) |
Net (decrease) increase in cash, cash equivalents and restricted cash | (38,405) | 21,740 |
Cash, cash equivalents and restricted cash, beginning of year | 151,452 | 34,184 |
Cash, cash equivalents and restricted cash, end of period | 113,047 | 55,924 |
Supplemental information | ||
Non-cash additions to property, plant and equipment | 1,895 | 1,161 |
Non-cash additions to right-of-use assets obtained in exchange for operating lease obligations | 1,291 | 2,020 |
Non-cash additions to right-of-use assets obtained in exchange for finance lease obligations | 0 | 357 |
Dividend equivalents rights ("DERs") declared not paid | 477 | 231 |
Share repurchase liability (Note 10) | $ 2,347 | $ 6,976 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands | Total | Total Shareholders' Equity Attributable to Acushnet Holdings Corp. | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss, Net of Tax | Retained Earnings | Treasury Stock | Noncontrolling Interests |
Beginning balance (in shares) at Dec. 31, 2019 | 75,620 | |||||||
Beginning balance at Dec. 31, 2019 | $ 950,826 | $ 918,440 | $ 76 | $ 910,507 | $ (112,028) | $ 151,039 | $ (31,154) | $ 32,386 |
Changes in stockholders' equity | ||||||||
Net income | 9,401 | 8,877 | 8,877 | 524 | ||||
Other comprehensive loss | (17,631) | (17,631) | (17,631) | |||||
Share-based compensation | 2,023 | 2,023 | 2,023 | |||||
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares) | 29 | |||||||
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) | (368) | (368) | (368) | |||||
Purchases of common stock (Note 10) | (6,976) | (6,976) | (6,976) | |||||
Share repurchase liability (Note 10) | (6,976) | (6,976) | (6,976) | |||||
Dividends and dividend equivalents declared | (11,735) | (11,735) | (11,735) | |||||
Ending balance (in shares) at Mar. 31, 2020 | 75,649 | |||||||
Ending balance at Mar. 31, 2020 | 918,564 | 885,654 | $ 76 | 912,162 | (129,659) | 148,181 | (45,106) | 32,910 |
Beginning balance (in shares) at Dec. 31, 2019 | 75,620 | |||||||
Beginning balance at Dec. 31, 2019 | 950,826 | 918,440 | $ 76 | 910,507 | (112,028) | 151,039 | (31,154) | 32,386 |
Changes in stockholders' equity | ||||||||
Dividends and dividend equivalents declared | (47,269) | |||||||
Ending balance (in shares) at Dec. 31, 2020 | 75,666 | |||||||
Ending balance at Dec. 31, 2020 | 1,017,253 | 983,949 | $ 76 | 925,385 | (96,182) | 199,776 | (45,106) | 33,304 |
Changes in stockholders' equity | ||||||||
Net income | 86,820 | 84,958 | 84,958 | 1,862 | ||||
Other comprehensive loss | (1,978) | (1,978) | (1,978) | |||||
Share-based compensation | 5,369 | 5,369 | 5,369 | |||||
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares) | 181 | |||||||
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) | (3,945) | (3,945) | (3,945) | |||||
Purchases of common stock (Note 10) | (2,377) | (2,377) | (2,377) | |||||
Share repurchase liability (Note 10) | (2,347) | (2,347) | (2,347) | |||||
Dividends and dividend equivalents declared | (12,767) | (12,767) | (12,767) | |||||
Dividends declared to noncontrolling interests | (48) | (48) | ||||||
Ending balance (in shares) at Mar. 31, 2021 | 75,847 | |||||||
Ending balance at Mar. 31, 2021 | $ 1,085,980 | $ 1,050,862 | $ 76 | $ 926,809 | $ (98,160) | $ 271,967 | $ (49,830) | $ 35,118 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of results to be expected for the full year ending December 31, 2021, nor were those of the comparable 2020 period representative of those actually experienced for the full year ended December 31, 2020. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2020 included in its Annual Report on Form 10-K filed with the SEC on February 25, 2021. Risks and Uncertainties In March 2020, the World Health Organization declared a pandemic related to the novel coronavirus (“COVID-19”), which led to government-ordered shutdowns of non-essential businesses, travel restrictions and restrictions on public gatherings. As a result of the government-ordered shutdowns, the Company was forced to temporarily close or substantially limit operations in its manufacturing facilities and distribution centers in the United States and Europe from mid-March 2020 through mid-May 2020, which disrupted business to varying degrees across many regions. The Company's manufacturing facilities and distribution centers reopened in mid-May 2020 and substantially all golf courses, on-course retail pro shops and off-course retail partner locations in the United States and Europe reopened by June 2020. The game of golf experienced a surge in rounds of play around the world primarily during the second half of 2020, in part due to its outdoor field of play and ease of social distancing, and rounds of play remained high through the first quarter of 2021. While government-ordered shutdowns and restrictions have eased in most regions and mass vaccination programs are underway, it is nevertheless possible that a resurgence of positive cases could prompt a return to tighter restrictions in certain regions, as with the lockdown in the United Kingdom during the first quarter of 2021. While the Company has seen increased rounds of play and demand for golf and golf-related products, as mass vaccinations programs advance and restrictions are further eased on other activities, the increase in rounds of play and demand for golf-related products could decrease. The Company has evaluated and continues to evaluate the potential impact of the COVID-19 pandemic on its consolidated financial statements. The impact of the COVID-19 pandemic continues to evolve, and both the full impact and duration of the COVID-19 pandemic remain highly uncertain. Accordingly, the Company's business, results of operations, financial position and cash flows could be materially impacted in ways that the Company cannot currently predict. Use of Estimates The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company has also made estimates related to the impact of the COVID-19 pandemic within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods. Actual results could differ from these estimates. Variable Interest Entities VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company consolidates the accounts of Acushnet Lionscore Limited, a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of March 31, 2021 and December 31, 2020. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE. Noncontrolling Interests and Redeemable Noncontrolling Interest The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The financial results and position of the noncontrolling interests are included in their entirety in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. The value attributable to the redeemable noncontrolling interest and the related loan to the minority shareholders, which is recorded as a reduction to redeemable noncontrolling interest, is presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders included in temporary equity on the unaudited condensed consolidated balance sheets was $4.4 million as of both March 31, 2021 and December 31, 2020. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively. Cash, Cash Equivalents and Restricted Cash Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. As of both March 31, 2021 and December 31, 2020, the amount of restricted cash included in cash, cash equivalents and restricted cash on the unaudited condensed consolidated balance sheets was $2.0 million. Foreign Currency Translation and Transactions Foreign currency transaction losses included in selling, general and administrative expense were $1.0 million for each of the three months ended March 31, 2021 and 2020. Recently Adopted Accounting Standards Income Taxes On January 1, 2021, the Company adopted Accounting Standards Update ("ASU") 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes" ("ASU 2019-12"). The amendments in this update simplified the accounting for income taxes by removing certain exceptions to general principles in Topic 740. The amendments also improved consistent application and simplified U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The adoption of this standard did not have a material impact on the consolidated financial statements. |
Accounts Receivable
Accounts Receivable | 3 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Accounts Receivable | Accounts Receivable The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current and forecasted economic conditions (including the impact of the COVID-19 pandemic) which could affect the collectability of the reported amounts. All of these factors have been considered in the estimate of expected credit losses. The activity related to the allowance for doubtful accounts for the periods presented was as follows: Three months ended March 31, (in thousands) 2021 2020 Balance at beginning of period $ 7,698 $ 5,338 Bad debt (recovery) expense (445) 916 Amount of receivables written off (144) (286) Foreign currency translation and other (32) (186) Balance at end of period $ 7,077 $ 5,782 |
Inventories
Inventories | 3 Months Ended |
Mar. 31, 2021 | |
Inventory Disclosure [Abstract] | |
Inventories | Inventories The components of inventories were as follows: March 31, December 31, (in thousands) 2021 2020 Raw materials and supplies $ 73,080 $ 74,302 Work-in-process 25,077 22,913 Finished goods 232,008 260,467 Inventories $ 330,165 $ 357,682 |
Product Warranty
Product Warranty | 3 Months Ended |
Mar. 31, 2021 | |
Product Warranties Disclosures [Abstract] | |
Product Warranty | Product Warranty The Company has defined warranties generally ranging from one The activity related to the Company’s warranty obligation for accrued warranty expense was as follows: Three months ended March 31, (in thousands) 2021 2020 Balance at beginning of period $ 3,831 $ 4,048 Provision 1,029 1,209 Claims paid/costs incurred (918) (944) Foreign currency translation and other (43) (164) Balance at end of period $ 3,899 $ 4,149 |
Debt and Financing Arrangements
Debt and Financing Arrangements | 3 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Debt and Financing Arrangements | Debt and Financing Arrangements Credit Facility The credit facility includes a revolving credit facility and a term loan facility. There were outstanding borrowings under the revolving credit facility of $15.9 million as of March 31, 2021. The weighted average interest rate applicable to these outstanding borrowings was 1.79% as of March 31, 2021. There were no outstanding borrowings under the revolving credit facility as of December 31, 2020. As of March 31, 2021, the Company had available borrowings under its revolving credit facility of $376.0 million after giving effect to $8.1 million of outstanding letters of credit. On July 3, 2020, the Company amended its credit agreement dated December 23, 2019 (the “First Amendment”) to, among other things, modify the maximum net average total leverage ratio, the interest rate margins, commitment fee and covenant baskets for each of the fiscal quarters ending after June 30, 2020 and on or before September 30, 2021 (the “Covenant Relief Period”). On March 5, 2021, the Company issued a notice exercising its right to an early termination of the Covenant Relief Period and as such is now required to comply with the previous maximum net average total leverage ratio, and the interest rate margins, commitment fee and covenant baskets reverted to the levels in effect prior to the First Amendment as discussed below. In connection with terminating the Covenant Relief Period, the Company recorded additional interest expense of approximately $0.7 million related to the acceleration of unamortized debt issuance costs for the three months ended March 31, 2021. Borrowings under the credit facility bear interest at a rate per annum equal to, at the applicable Borrower’s option, either (a) a base rate determined by reference to the highest of (1) the prime rate of Wells Fargo, (2) the federal funds effective rate plus 0.50% and (3) a Eurodollar Rate, subject to certain adjustments, plus 1.00% or (b) a Eurodollar Rate (or, in the case of Canadian borrowings, a Canadian Dollar Offered Rate), subject to certain adjustments, in each case, plus an applicable margin. Under the credit agreement, the applicable margin is 0% to 0.75% for base rate borrowings and 1.00% to 1.75% for Eurodollar rate or Canadian Dollar Offered Rate borrowings, in each case, depending on the Net Average Total Leverage Ratio (as defined in the credit agreement). In addition, the Company is required to pay a commitment fee on any unutilized commitments under the revolving credit facility. The commitment fee rate payable in respect of unused portions of the revolving credit facility is 0.15% to 0.30% per annum, depending on the Net Average Total Leverage Ratio. The initial commitment fee rate is 0.20% per annum. The maximum net average total leverage ratio under the credit facility is 3.50 to 1.00, which is subject to increase to 3.75 to 1.00 in connection with certain acquisitions, and the minimum consolidated interest coverage ratio (as defined in the credit agreement) is 3.00 to 1.00. The credit agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on the Company's leverage and interest coverage ratios. The credit agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2021, the Company was in compliance with all covenants under the credit agreement. Other Short-Term Borrowings The Company has certain unsecured local credit facilities available through its subsidiaries. There were outstanding borrowings under the Company's local credit facilities of $8.8 million and $2.8 million as of March 31, 2021 and December 31, 2020, respectively. The weighted average interest rate applicable to the outstanding borrowings was 0.28% and 2.00% as of March 31, 2021 and December 31, 2020, respectively. As of March 31, 2021, the Company had available borrowings remaining under these local credit facilities of $50.3 million. Letters of Credit |
Derivative Financial Instrument
Derivative Financial Instruments | 3 Months Ended |
Mar. 31, 2021 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments | Derivative Financial InstrumentsThe Company principally uses derivative financial instruments to reduce the impact of foreign currency fluctuations and interest rate variability on the Company's results of operations. The principal derivative financial instruments the Company enters into are foreign exchange forward contracts and interest rate swaps. The Company does not enter into derivative financial instrument contracts for trading or speculative purposes. Foreign Exchange Derivative Instruments Foreign exchange forward contracts are foreign exchange derivative instruments primarily used to reduce foreign currency risk related to transactions denominated in a currency other than functional currency. These instruments are designated as cash flow hedges. The periods of the foreign exchange forward contracts correspond to the periods of the hedged forecasted transactions, which do not exceed 24 months subsequent to the latest balance sheet date. The primary foreign exchange forward contracts pertain to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won and the euro. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts designated under hedge accounting as of March 31, 2021 and December 31, 2020 was $219.0 million and $248.1 million, respectively. As a result of the impact of the COVID-19 pandemic, during the three months ended March 31, 2020, the Company de-designated certain foreign exchange cash flow hedges deemed ineffective, none of which were outstanding as of March 31, 2021 or December 31, 2020. The Company also enters into foreign exchange forward contracts, which do not qualify as hedging instruments, to reduce foreign currency transaction risk related to certain intercompany assets and liabilities denominated in a currency other than functional currency. These undesignated instruments are recorded at fair value as a derivative asset or liability with the corresponding change in fair value recognized in selling, general and administrative expense. There were no outstanding foreign exchange forward contracts not designated under hedge accounting as of March 31, 2021 and December 31, 2020. Interest Rate Derivative Instruments The Company enters into interest rate swap contracts to reduce interest rate risk related to floating rate debt. Under the contracts, the Company pays fixed and receives variable rate interest, in effect converting a portion of its floating rate debt to fixed rate debt. The interest rate swap contracts are accounted for as cash flow hedges. As of March 31, 2021 and December 31, 2020, the notional value of the Company's outstanding interest rate swap contracts was $140.0 million. Impact on Financial Statements The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows: (in thousands) March 31, December 31, Balance Sheet Location Hedge Instrument Type 2021 2020 Prepaid and other assets Foreign exchange forward $ 3,476 $ 1,166 Other assets Foreign exchange forward 1,225 30 Accrued expenses and other liabilities Foreign exchange forward 3,929 6,400 Interest rate swap 621 1,571 Other noncurrent liabilities Foreign exchange forward 92 985 The hedge instrument gain (loss) recognized in accumulated other comprehensive loss, net of tax was as follows: Three months ended March 31, (in thousands) 2021 2020 Type of hedge Foreign exchange forward $ 4,376 $ 9,467 Interest rate swap (9) (2,065) Total $ 4,367 $ 7,402 Gains and losses on derivative instruments designated as cash flow hedges are reclassified from accumulated other comprehensive loss, net of tax at the time the forecasted hedged transaction impacts the statements of operations or at the time the hedge is determined to be ineffective. Based on the current valuation, during the next 12 months the Company expects to reclassify a net loss of $3.2 million related to foreign exchange derivative instruments from accumulated other comprehensive loss, net of tax, into cost of goods sold and a net loss of $0.6 million related to interest rate derivative instruments from accumulated other comprehensive loss, net of tax into interest expense, net. For further information related to amounts recognized in accumulated other comprehensive loss, net of tax, see Note 12. The hedge instrument gain (loss) recognized on the unaudited condensed consolidated statements of operations was as follows: Three months ended March 31, (in thousands) 2021 2020 Location of gain (loss) in statement of operations Foreign exchange forward: Cost of goods sold $ 396 $ 1,542 Selling, general and administrative (1)(2) 640 1,534 Total $ 1,036 $ 3,076 Interest Rate Swap: Interest expense, net $ (959) $ (478) Total $ (959) $ (478) _______________________________________________________________________________ (1) Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges. (2) Selling, general and administrative expense for the three months ended March 31, 2020 excludes net gains of $0.7 million reclassified out of accumulated other comprehensive loss, net of tax related to hedges deemed ineffective. Credit Risk The Company enters into derivative contracts with major financial institutions with investment grade credit ratings and is exposed to credit losses in the event of non-performance by these financial institutions. This credit risk is generally limited to the unrealized gains in the derivative contracts. However, the Company monitors the credit quality of these financial institutions, as well as its own credit quality, and considers the risk of counterparty default to be minimal. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Assets and liabilities measured at fair value on a recurring basis as of March 31, 2021 were as follows: Fair Value Measurements as of March 31, 2021 using: (in thousands) Level 1 Level 2 Level 3 Balance Sheet Location Assets Rabbi trust $ 5,046 $ — $ — Prepaid and other assets Foreign exchange derivative instruments — 3,476 — Prepaid and other assets Deferred compensation program assets 803 — — Other assets Foreign exchange derivative instruments — 1,225 — Other assets Total assets $ 5,849 $ 4,701 $ — Liabilities Foreign exchange derivative instruments $ — $ 3,929 $ — Accrued expenses and other liabilities Interest rate derivative instruments — 621 — Accrued expenses and other liabilities Deferred compensation program liabilities 803 — — Other noncurrent liabilities Foreign exchange derivative instruments — 92 — Other noncurrent liabilities Total liabilities $ 803 $ 4,642 $ — Assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 were as follows: Fair Value Measurements as of December 31, 2020 using: (in thousands) Level 1 Level 2 Level 3 Balance Sheet Location Assets Rabbi trust $ 5,160 $ — $ — Prepaid and other assets Foreign exchange derivative instruments — 1,166 — Prepaid and other assets Deferred compensation program assets 802 — — Other assets Foreign exchange derivative instruments — 30 — Other assets Total assets $ 5,962 $ 1,196 $ — Liabilities Foreign exchange derivative instruments $ — $ 6,400 $ — Accrued expenses and other liabilities Interest rate derivative instruments — 1,571 — Accrued expenses and other liabilities Deferred compensation program liabilities 802 — — Other noncurrent liabilities Foreign exchange derivative instruments — 985 — Other noncurrent liabilities Total liabilities $ 802 $ 8,956 $ — Rabbi trust assets are used to fund certain retirement obligations of the Company. The assets underlying the Rabbi trust are equity and fixed income exchange-traded funds. Deferred compensation program assets and liabilities represent a program where select employees could defer compensation until termination of employment. Effective July 29, 2011, this program was amended to cease all employee compensation deferrals and provided for the distribution of all previously deferred employee compensation. The program remains in effect with respect to the value attributable to the employer match contributed prior to July 29, 2011. Foreign exchange derivative instruments are foreign exchange forward contracts primarily used to limit currency risk that would otherwise result from changes in foreign exchange rates (Note 6). The Company uses the mid-price of foreign exchange forward rates as of the close of business on the valuation date to value each foreign exchange forward contract at each reporting period. Interest rate derivative instruments are interest rate swap contracts used to reduce interest rate risk related to the Company's floating rate debt (Note 6). The valuation for the interest rate swap is calculated as the net of the discounted future cash flows of the pay and receive legs of the swap. Mid-market interest rates on the valuation date are used to create the forward curve for floating legs and discount curve. |
Pension and Other Postretiremen
Pension and Other Postretirement Benefits | 3 Months Ended |
Mar. 31, 2021 | |
Retirement Benefits [Abstract] | |
Pension and Other Postretirement Benefits | Pension and Other Postretirement Benefits Components of net periodic benefit cost (income) were as follows: Pension Benefits Postretirement Benefits Three months ended March 31, (in thousands) 2021 2020 2021 2020 Components of net periodic benefit cost Service cost $ 2,135 $ 2,316 $ 162 $ 171 Interest cost 1,951 2,512 75 112 Expected return on plan assets (2,547) (2,903) — — Settlement expense 1,419 — — — Amortization of net loss (gain) 1,421 964 (65) (214) Amortization of prior service cost (credit) 71 70 (34) (34) Net periodic benefit cost $ 4,450 $ 2,959 $ 138 $ 35 The non-service cost components of net periodic benefit cost (income) are included in other expense, net in the unaudited condensed consolidated statements of operations. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Income tax expense increased by $20.2 million to $27.8 million for the three months ended March 31, 2021 compared to $7.6 million for the three months ended March 31, 2020. The Company’s effective tax rate ("ETR") was 24.3% for the three months ended March 31, 2021 compared to 46.0% for the three months ended March 31, 2020. The ETR for the three months ended March 31, 2021 differed from the U.S. statutory tax rate primarily due to the U.S. taxation of foreign income and the geographic mix of income earned by the Company's international subsidiaries, partially offset by the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits. |
Common Stock
Common Stock | 3 Months Ended |
Mar. 31, 2021 | |
Equity [Abstract] | |
Common Stock | Common Stock Dividends The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows: Dividends per Common Share Amount (in thousands) 2021: First Quarter $ 0.165 $ 12,767 Total dividends declared in 2021 $ 0.165 $ 12,767 2020: Fourth Quarter $ 0.155 $ 11,983 Third Quarter 0.155 11,790 Second Quarter 0.155 11,761 First Quarter 0.155 11,735 Total dividends declared in 2020 $ 0.620 $ 47,269 During the second quarter of 2021, the Company's Board of Directors declared a dividend of $0.165 per share of common stock to shareholders of record as of June 4, 2021 and payable on June 18, 2021. Share Repurchase Program As of March 31, 2021, the Board of Directors had authorized the Company to repurchase up to an aggregate of $100.0 million of its issued and outstanding common stock. In April 2020, the Company temporarily suspended stock repurchases under its share repurchase program in light of the COVID-19 pandemic. In March 2021, the Company resumed share repurchases under its share repurchase program. Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at the discretion of the Company consistent with the Company's general working capital needs and within the constraints of the Company’s credit agreement. As previously disclosed, in connection with this share repurchase program, the Company entered into an agreement with Magnus Holdings Co., Ltd. (“Magnus”), a wholly-owned subsidiary of Fila Holdings Corp., to purchase from Magnus an equal amount of its common stock as it purchases on the open market, up to an aggregate of $24.9 million, at the same weighted average per share price. The Company's share repurchase activity was as follows: Three months ended March 31, (in thousands, except share and per share amounts) 2021 2020 Shares repurchased in the open market: Shares repurchased 56,156 243,894 Average price $ 42.34 $ 28.60 Aggregate value $ 2,377 $ 6,976 In relation to the Magnus share repurchase agreement, the Company recorded a share repurchase liability of $11.1 million and $8.8 million for 355,341 and 299,894 shares of common stock to be repurchased from Magnus, which was included in accrued expenses and other liabilities and treasury stock on the unaudited condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020, respectively. Excluding the impact of the share repurchase liability, as of March 31, 2021, the Company had $61.3 million remaining under the current share repurchase authorization, including $11.1 million related to the Magnus share repurchase agreement. As the Company repurchased a cumulative total of $24.9 million of common stock through open market purchases, the determination date, as defined in the Magnus share repurchase agreement, was automatically triggered on March 18, 2021. As a result, on April 2, 2021, the Company repurchased from Magnus 355,341 shares of common stock for an aggregate $11.1 million. At the completion of this transaction, the Company no longer had an obligation to repurchase shares of common stock from Magnus. |
Equity Incentive Plans
Equity Incentive Plans | 3 Months Ended |
Mar. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Equity Incentive Plans | Equity Incentive Plans Under the Acushnet Holdings Corp. 2015 Omnibus Incentive Plan (“2015 Plan”), the Company may grant stock options, stock appreciation rights, restricted shares of common stock, restricted stock units ("RSUs"), performance stock units ("PSUs") and other share-based and cash-based awards to members of the Board of Directors, officers, employees, consultants and advisors of the Company. As of March 31, 2021, the only awards granted under the 2015 Plan were RSUs and PSUs. Restricted Stock and Performance Stock Units RSUs granted to members of the Board of Directors vest immediately into shares of common stock. RSUs granted to Company officers generally vest over three years, with one-third of each grant vesting annually, subject to the recipient's continued employment with the Company. RSUs granted to other employees, consultants and advisors of the Company vest in accordance with the terms of the grants, generally over three years, subject to the recipient’s continued service to the Company. PSUs vest, subject to the recipient's continued employment with the Company, based upon the Company's performance against specified metrics which are generally over a three year performance period. At the end of the performance period, the number of shares of common stock that could be issued is determined based upon the Company's performance against these metrics. The number of shares that could be issued can range from 0% to 200% of the recipient's target award. Recipients of the awards granted under the 2015 Plan may elect to defer receipt of all or any portion of any shares of common stock issuable upon vesting to a future date elected by the recipient. All RSUs and PSUs granted under the 2015 Plan have DERs, which entitle holders of RSUs and PSUs to the same dividend value per share as holders of common stock and can be paid in either cash or common stock. DERs are subject to the same vesting and other terms and conditions as the corresponding unvested RSUs and PSUs. DERs are paid when the underlying shares of common stock are delivered. A summary of the Company’s RSUs and PSUs as of March 31, 2021 and changes during the three months then ended is presented below: Weighted- Weighted- Number Average Number Average of RSUs Fair Value RSUs of PSUs Fair Value PSUs Outstanding as of December 31, 2020 1,253,173 $ 24.33 457,576 $ 24.55 Granted 289,259 45.36 145,110 45.36 Vested (1) (362,605) 24.11 — — Forfeited (20,290) 24.24 (2,631) 25.45 Outstanding as of March 31, 2021 1,159,537 $ 29.65 600,055 $ 29.58 _______________________________________________________________________________ (1) Includes 110,514 shares of common stock related to RSUs and no shares of common stock related to PSUs that were not delivered as of March 31, 2021. A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below: Three months ended Three months ended March 31, 2021 March 31, 2020 RSUs PSUs RSUs PSUs Shares of common stock issued 270,779 — 42,797 — Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (89,938) — (13,831) — Net shares of common stock issued 180,841 — 28,966 — Cumulative undelivered shares of common stock 395,670 — 240,512 — Compensation expense recorded related to RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows: Three months ended March 31, (in thousands) 2021 2020 RSUs $ 2,359 $ 2,478 PSUs 3,010 (455) During the three months ended March 31, 2020, the Company adjusted the estimate of its performance against metrics for certain PSUs downward, resulting in a reversal of previously recognized share-based compensation expense. During both the second half of 2020 and the three months ended March 31, 2021, based on updated forecast information, the Company increased the estimate of its performance against metrics for these PSUs and recognized additional cumulative share-based compensation expense in both periods. The remaining unrecognized compensation expense related to unvested RSUs and unvested PSUs was $23.4 million and $13.0 million, respectively, as of March 31, 2021 and is expected to be recognized over the related weighted average period of 2.3 years and 2.2 years, respectively. Compensation Expense The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows: Three months ended March 31, (in thousands) 2021 2020 Cost of goods sold $ (7) $ 225 Selling, general and administrative 5,381 1,714 Research and development 159 248 Total compensation expense before income tax 5,533 2,187 Income tax benefit 1,267 463 Total compensation expense, net of income tax $ 4,266 $ 1,724 |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss, Net of Tax | 3 Months Ended |
Mar. 31, 2021 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Loss, Net of Tax | Accumulated Other Comprehensive Loss, Net of Tax Accumulated other comprehensive loss, net of tax consists of foreign currency translation adjustments, unrealized gains and losses from derivative instruments designated as cash flow hedges (Note 6) and pension and other postretirement adjustments (Note 8). The components of and changes in accumulated other comprehensive loss, net of tax, were as follows: Foreign Gains (Losses) on Gains (Losses) on Pension and Accumulated Currency Foreign Exchange Interest Rate Other Other Translation Derivative Swap Derivative Postretirement Comprehensive (in thousands) Adjustments Instruments Instruments Adjustments Loss, Net of Tax Balance as of December 31, 2020 $ (43,906) $ (4,471) $ (1,179) $ (46,626) $ (96,182) Other comprehensive income (loss) before reclassifications (7,080) 4,376 (9) (237) (2,950) Amounts reclassified from accumulated other comprehensive loss, net of tax — (396) 959 2,812 3,375 Tax expense — (1,435) (229) (739) (2,403) Balance as of March 31, 2021 $ (50,986) $ (1,926) $ (458) $ (44,790) $ (98,160) |
Net Income per Common Share
Net Income per Common Share | 3 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Net Income per Common Share | Net Income per Common Share The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.: Three months ended March 31, (in thousands, except share and per share amounts) 2021 2020 Net income attributable to Acushnet Holdings Corp. $ 84,958 $ 8,877 Weighted average number of common shares: Basic 74,778,189 74,545,280 Diluted 75,255,312 75,099,930 Net income per common share attributable to Acushnet Holdings Corp.: Basic $ 1.14 $ 0.12 Diluted $ 1.13 $ 0.12 Net income per common share attributable to Acushnet Holdings Corp. for the three months ended March 31, 2021 and 2020 was calculated using the treasury stock method. The Company’s potential dilutive securities for the three months ended March 31, 2021 and 2020 include RSUs and PSUs. PSUs vest based upon achievement of performance targets and are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the applicable reporting period regardless of whether such performance targets are probable of achievement. For the three months ended March 31, 2021 and 2020, the following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive: Three months ended March 31, 2021 2020 RSUs 291,484 — |
Segment Information
Segment Information | 3 Months Ended |
Mar. 31, 2021 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information The Company’s operating segments are based on how the Chief Operating Decision Maker (“CODM”) makes decisions about assessing performance and allocating resources. The Company has four reportable segments that are organized on the basis of product categories. These segments include Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear. The CODM primarily evaluates performance using segment operating income (loss). Segment operating income (loss) includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the reportable segments, but excludes interest expense, net, restructuring charges, the non-service cost component of net periodic benefit cost, transaction fees and other non-operating gains and losses as the Company does not allocate these to the reportable segments. The CODM does not evaluate a measure of assets when assessing performance. Results shown for the three months ended March 31, 2021 and 2020 are not necessarily those which would be achieved if each segment was an unaffiliated business enterprise. There are no intersegment transactions. Information by reportable segment and a reconciliation to reported amounts are as follows: Three months ended March 31, (in thousands) 2021 2020 Net sales Titleist golf balls $ 173,637 $ 116,239 Titleist golf clubs 155,827 93,214 Titleist golf gear 53,120 43,525 FootJoy golf wear 159,434 130,387 Other 38,867 25,376 Total net sales $ 580,885 $ 408,741 Segment operating income Titleist golf balls $ 34,317 $ 3,243 Titleist golf clubs 41,799 4,503 Titleist golf gear 9,728 8,865 FootJoy golf wear 28,117 14,297 Other 6,471 1,080 Total segment operating income 120,432 31,988 Reconciling items: Interest expense, net (3,616) (4,123) Restructuring charges — (11,628) Non-service cost component of net periodic benefit cost (2,291) (507) Other (64) 885 Total income before income tax $ 114,461 $ 16,615 Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates. Three months ended March 31, (in thousands) 2021 2020 United States $ 308,636 $ 211,008 EMEA (1) 80,575 74,671 Japan 56,377 37,556 Korea 79,097 50,449 Rest of world 56,200 35,057 Total net sales $ 580,885 $ 408,741 _______________________________________________________________________________ (1) Europe, the Middle East and Africa ("EMEA") |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Purchase Obligations During the normal course of its business, the Company enters into agreements to purchase goods and services, including purchase commitments for production materials, finished goods inventory, capital expenditures and endorsement arrangements with professional golfers. The Company's purchase obligations as of March 31, 2021 were as follows: Payments Due by Period Remainder of (in thousands) 2021 2022 2023 2024 2025 Thereafter Purchase obligations (1) $ 200,097 $ 16,026 $ 3,282 $ 2,545 $ 2,549 $ 1,284 _______________________________________________________________________________ (1) The reported amounts exclude those liabilities included on the unaudited condensed consolidated balance sheet as of March 31, 2021. Litigation |
Restructuring Charges
Restructuring Charges | 3 Months Ended |
Mar. 31, 2021 | |
Restructuring and Related Activities [Abstract] | |
Restructuring Charges | Restructuring Charges During the first quarter of 2020, management approved a restructuring program to refine its business model and improve operational efficiencies. This program included both a voluntary bridge to retirement ("VBR") program for certain eligible employees and involuntary headcount reductions ("Other"). The VBR program was part of the Company's long-term strategic planning process and was designed to bridge eligible employees to retirement. As part of this program, employees were offered severance in the form of salary continuation, including benefits, as well as accrued bonus incentives. Costs associated with the involuntary headcount reductions include severance and other benefits related to these headcount reductions. The Company recorded cumulative severance and other benefits expense of $11.2 million related to its VBR program and $2.0 million related to its Other restructuring program, of which $11.2 million and $0.4 million was recorded during the three months ended March 31, 2020 related to the VBR program and Other program, respectively. There are no further costs expected to be incurred in relation to these programs. The activity related to the Company’s restructuring programs was as follows: Three months ended March 31, 2021 (in thousands) VBR Other Balance at beginning of period $ 6,243 $ 778 Payments (2,161) (565) Foreign currency translation and other — (1) Balance at end of period $ 4,082 $ 212 The restructuring program liabilities recognized on the unaudited condensed consolidated balance sheets were as follows: (in thousands) March 31, December 31, Balance Sheet Location Restructuring Program 2021 2020 Accrued compensation and benefits VBR $ 4,039 $ 6,018 Other 212 778 Other noncurrent liabilities VBR 43 225 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company has also made estimates related to the impact of the COVID-19 pandemic within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods. Actual results could differ from these estimates. |
Variable Interest Entities | Variable Interest Entities VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company consolidates the accounts of Acushnet Lionscore Limited, a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of March 31, 2021 and December 31, 2020. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE. |
Noncontrolling Interests and Redeemable Noncontrolling Interest | Noncontrolling Interests and Redeemable Noncontrolling Interest The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The financial results and position of the noncontrolling interests are included in their entirety in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. The value attributable to the redeemable noncontrolling interest and the related loan to the minority shareholders, which is recorded as a reduction to redeemable noncontrolling interest, is presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders included in temporary equity on the unaudited condensed consolidated balance sheets was $4.4 million as of both March 31, 2021 and December 31, 2020. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively. |
Cash, Cash Equivalents and Restricted Cash | Cash, Cash Equivalents and Restricted CashCash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. |
Foreign Currency Translation and Transactions | Foreign Currency Translation and Transactions Foreign currency transaction losses included in selling, general and administrative expense were $1.0 million for each of the three months ended March 31, 2021 and 2020. |
Recently Adopted Accounting Standards | Recently Adopted Accounting Standards Income Taxes On January 1, 2021, the Company adopted Accounting Standards Update ("ASU") 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes" ("ASU 2019-12"). The amendments in this update simplified the accounting for income taxes by removing certain exceptions to general principles in Topic 740. The amendments also improved consistent application and simplified U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The adoption of this standard did not have a material impact on the consolidated financial statements. |
Accounts Receivable | The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current and forecasted economic conditions (including the impact of the COVID-19 pandemic) which could affect the collectability of the reported amounts. All of these factors have been considered in the estimate of expected credit losses. |
Accounts Receivable (Tables)
Accounts Receivable (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Activity Related to the Allowance for Doubtful Accounts | The activity related to the allowance for doubtful accounts for the periods presented was as follows: Three months ended March 31, (in thousands) 2021 2020 Balance at beginning of period $ 7,698 $ 5,338 Bad debt (recovery) expense (445) 916 Amount of receivables written off (144) (286) Foreign currency translation and other (32) (186) Balance at end of period $ 7,077 $ 5,782 |
Inventories (Tables)
Inventories (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | The components of inventories were as follows: March 31, December 31, (in thousands) 2021 2020 Raw materials and supplies $ 73,080 $ 74,302 Work-in-process 25,077 22,913 Finished goods 232,008 260,467 Inventories $ 330,165 $ 357,682 |
Product Warranty (Tables)
Product Warranty (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Product Warranties Disclosures [Abstract] | |
Schedule of Warranty Obligation for Accrued Warranty Expense | The activity related to the Company’s warranty obligation for accrued warranty expense was as follows: Three months ended March 31, (in thousands) 2021 2020 Balance at beginning of period $ 3,831 $ 4,048 Provision 1,029 1,209 Claims paid/costs incurred (918) (944) Foreign currency translation and other (43) (164) Balance at end of period $ 3,899 $ 4,149 |
Derivative Financial Instrume_2
Derivative Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets | The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows: (in thousands) March 31, December 31, Balance Sheet Location Hedge Instrument Type 2021 2020 Prepaid and other assets Foreign exchange forward $ 3,476 $ 1,166 Other assets Foreign exchange forward 1,225 30 Accrued expenses and other liabilities Foreign exchange forward 3,929 6,400 Interest rate swap 621 1,571 Other noncurrent liabilities Foreign exchange forward 92 985 |
Effect of Hedge Instruments on Accumulated Other Comprehensive Loss, Net of Tax | The hedge instrument gain (loss) recognized in accumulated other comprehensive loss, net of tax was as follows: Three months ended March 31, (in thousands) 2021 2020 Type of hedge Foreign exchange forward $ 4,376 $ 9,467 Interest rate swap (9) (2,065) Total $ 4,367 $ 7,402 |
Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations | The hedge instrument gain (loss) recognized on the unaudited condensed consolidated statements of operations was as follows: Three months ended March 31, (in thousands) 2021 2020 Location of gain (loss) in statement of operations Foreign exchange forward: Cost of goods sold $ 396 $ 1,542 Selling, general and administrative (1)(2) 640 1,534 Total $ 1,036 $ 3,076 Interest Rate Swap: Interest expense, net $ (959) $ (478) Total $ (959) $ (478) _______________________________________________________________________________ (1) Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges. |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis | Assets and liabilities measured at fair value on a recurring basis as of March 31, 2021 were as follows: Fair Value Measurements as of March 31, 2021 using: (in thousands) Level 1 Level 2 Level 3 Balance Sheet Location Assets Rabbi trust $ 5,046 $ — $ — Prepaid and other assets Foreign exchange derivative instruments — 3,476 — Prepaid and other assets Deferred compensation program assets 803 — — Other assets Foreign exchange derivative instruments — 1,225 — Other assets Total assets $ 5,849 $ 4,701 $ — Liabilities Foreign exchange derivative instruments $ — $ 3,929 $ — Accrued expenses and other liabilities Interest rate derivative instruments — 621 — Accrued expenses and other liabilities Deferred compensation program liabilities 803 — — Other noncurrent liabilities Foreign exchange derivative instruments — 92 — Other noncurrent liabilities Total liabilities $ 803 $ 4,642 $ — Assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 were as follows: Fair Value Measurements as of December 31, 2020 using: (in thousands) Level 1 Level 2 Level 3 Balance Sheet Location Assets Rabbi trust $ 5,160 $ — $ — Prepaid and other assets Foreign exchange derivative instruments — 1,166 — Prepaid and other assets Deferred compensation program assets 802 — — Other assets Foreign exchange derivative instruments — 30 — Other assets Total assets $ 5,962 $ 1,196 $ — Liabilities Foreign exchange derivative instruments $ — $ 6,400 $ — Accrued expenses and other liabilities Interest rate derivative instruments — 1,571 — Accrued expenses and other liabilities Deferred compensation program liabilities 802 — — Other noncurrent liabilities Foreign exchange derivative instruments — 985 — Other noncurrent liabilities Total liabilities $ 802 $ 8,956 $ — |
Pension and Other Postretirem_2
Pension and Other Postretirement Benefits (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Retirement Benefits [Abstract] | |
Schedule of Components of Net Periodic Benefit Cost (Income) | Components of net periodic benefit cost (income) were as follows: Pension Benefits Postretirement Benefits Three months ended March 31, (in thousands) 2021 2020 2021 2020 Components of net periodic benefit cost Service cost $ 2,135 $ 2,316 $ 162 $ 171 Interest cost 1,951 2,512 75 112 Expected return on plan assets (2,547) (2,903) — — Settlement expense 1,419 — — — Amortization of net loss (gain) 1,421 964 (65) (214) Amortization of prior service cost (credit) 71 70 (34) (34) Net periodic benefit cost $ 4,450 $ 2,959 $ 138 $ 35 |
Common Stock (Tables)
Common Stock (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Equity [Abstract] | |
Schedule of Declared Dividends Per Share | The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows: Dividends per Common Share Amount (in thousands) 2021: First Quarter $ 0.165 $ 12,767 Total dividends declared in 2021 $ 0.165 $ 12,767 2020: Fourth Quarter $ 0.155 $ 11,983 Third Quarter 0.155 11,790 Second Quarter 0.155 11,761 First Quarter 0.155 11,735 Total dividends declared in 2020 $ 0.620 $ 47,269 |
Schedule of Share Repurchase Activity | The Company's share repurchase activity was as follows: Three months ended March 31, (in thousands, except share and per share amounts) 2021 2020 Shares repurchased in the open market: Shares repurchased 56,156 243,894 Average price $ 42.34 $ 28.60 Aggregate value $ 2,377 $ 6,976 |
Equity Incentive Plans (Tables)
Equity Incentive Plans (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Summary of Restricted and Performance Stock Units | A summary of the Company’s RSUs and PSUs as of March 31, 2021 and changes during the three months then ended is presented below: Weighted- Weighted- Number Average Number Average of RSUs Fair Value RSUs of PSUs Fair Value PSUs Outstanding as of December 31, 2020 1,253,173 $ 24.33 457,576 $ 24.55 Granted 289,259 45.36 145,110 45.36 Vested (1) (362,605) 24.11 — — Forfeited (20,290) 24.24 (2,631) 25.45 Outstanding as of March 31, 2021 1,159,537 $ 29.65 600,055 $ 29.58 _______________________________________________________________________________ |
Summary of Shares of Common Stock Issued | A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below: Three months ended Three months ended March 31, 2021 March 31, 2020 RSUs PSUs RSUs PSUs Shares of common stock issued 270,779 — 42,797 — Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (89,938) — (13,831) — Net shares of common stock issued 180,841 — 28,966 — Cumulative undelivered shares of common stock 395,670 — 240,512 — |
Compensation Expense Recorded in the Consolidated Statement of Operations | Compensation expense recorded related to RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows: Three months ended March 31, (in thousands) 2021 2020 RSUs $ 2,359 $ 2,478 PSUs 3,010 (455) |
Schedule of Compensation Expense Related to Equity Incentive Plans | The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows: Three months ended March 31, (in thousands) 2021 2020 Cost of goods sold $ (7) $ 225 Selling, general and administrative 5,381 1,714 Research and development 159 248 Total compensation expense before income tax 5,533 2,187 Income tax benefit 1,267 463 Total compensation expense, net of income tax $ 4,266 $ 1,724 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Loss, Net of Tax (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Equity [Abstract] | |
Schedule of Changes in Each Component of Accumulated Comprehensive Loss, Net of Tax Effects | The components of and changes in accumulated other comprehensive loss, net of tax, were as follows: Foreign Gains (Losses) on Gains (Losses) on Pension and Accumulated Currency Foreign Exchange Interest Rate Other Other Translation Derivative Swap Derivative Postretirement Comprehensive (in thousands) Adjustments Instruments Instruments Adjustments Loss, Net of Tax Balance as of December 31, 2020 $ (43,906) $ (4,471) $ (1,179) $ (46,626) $ (96,182) Other comprehensive income (loss) before reclassifications (7,080) 4,376 (9) (237) (2,950) Amounts reclassified from accumulated other comprehensive loss, net of tax — (396) 959 2,812 3,375 Tax expense — (1,435) (229) (739) (2,403) Balance as of March 31, 2021 $ (50,986) $ (1,926) $ (458) $ (44,790) $ (98,160) |
Net Income per Common Share (Ta
Net Income per Common Share (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Schedule of Computation of Basic and Diluted Net Income Per Common Share | The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.: Three months ended March 31, (in thousands, except share and per share amounts) 2021 2020 Net income attributable to Acushnet Holdings Corp. $ 84,958 $ 8,877 Weighted average number of common shares: Basic 74,778,189 74,545,280 Diluted 75,255,312 75,099,930 Net income per common share attributable to Acushnet Holdings Corp.: Basic $ 1.14 $ 0.12 Diluted $ 1.13 $ 0.12 |
Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares | For the three months ended March 31, 2021 and 2020, the following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive: Three months ended March 31, 2021 2020 RSUs 291,484 — |
Segment Information (Tables)
Segment Information (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Segment Reporting [Abstract] | |
Schedule of Information by Reportable Segment and a Reconciliation to Reported Amounts | Information by reportable segment and a reconciliation to reported amounts are as follows: Three months ended March 31, (in thousands) 2021 2020 Net sales Titleist golf balls $ 173,637 $ 116,239 Titleist golf clubs 155,827 93,214 Titleist golf gear 53,120 43,525 FootJoy golf wear 159,434 130,387 Other 38,867 25,376 Total net sales $ 580,885 $ 408,741 Segment operating income Titleist golf balls $ 34,317 $ 3,243 Titleist golf clubs 41,799 4,503 Titleist golf gear 9,728 8,865 FootJoy golf wear 28,117 14,297 Other 6,471 1,080 Total segment operating income 120,432 31,988 Reconciling items: Interest expense, net (3,616) (4,123) Restructuring charges — (11,628) Non-service cost component of net periodic benefit cost (2,291) (507) Other (64) 885 Total income before income tax $ 114,461 $ 16,615 |
Schedule of Net Sales By Geographical Area | Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates. Three months ended March 31, (in thousands) 2021 2020 United States $ 308,636 $ 211,008 EMEA (1) 80,575 74,671 Japan 56,377 37,556 Korea 79,097 50,449 Rest of world 56,200 35,057 Total net sales $ 580,885 $ 408,741 _______________________________________________________________________________ (1) Europe, the Middle East and Africa ("EMEA") |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Purchase Obligations | The Company's purchase obligations as of March 31, 2021 were as follows: Payments Due by Period Remainder of (in thousands) 2021 2022 2023 2024 2025 Thereafter Purchase obligations (1) $ 200,097 $ 16,026 $ 3,282 $ 2,545 $ 2,549 $ 1,284 _______________________________________________________________________________ (1) The reported amounts exclude those liabilities included on the unaudited condensed consolidated balance sheet as of March 31, 2021. |
Restructuring and Related Activ
Restructuring and Related Activities (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Company's Restructuring Programs | The activity related to the Company’s restructuring programs was as follows: Three months ended March 31, 2021 (in thousands) VBR Other Balance at beginning of period $ 6,243 $ 778 Payments (2,161) (565) Foreign currency translation and other — (1) Balance at end of period $ 4,082 $ 212 The restructuring program liabilities recognized on the unaudited condensed consolidated balance sheets were as follows: (in thousands) March 31, December 31, Balance Sheet Location Restructuring Program 2021 2020 Accrued compensation and benefits VBR $ 4,039 $ 6,018 Other 212 778 Other noncurrent liabilities VBR 43 225 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Narrative (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Variable Interest Entity [Line Items] | ||
Loan to minority shareholders included in temporary equity | $ 4,400,000 | $ 4,400,000 |
Restricted cash | 2,000,000 | 2,000,000 |
Transaction gains (losses) included in selling, general and administrative expense | $ (1,000,000) | |
VIE | ||
Variable Interest Entity [Line Items] | ||
Ownership percentage | 40.00% | |
Outstanding borrowings | $ 0 | $ 0 |
Accounts Receivable (Details)
Accounts Receivable (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | ||
Balance at beginning of period | $ 7,698 | $ 5,338 |
Bad debt (recovery) expense | (445) | 916 |
Amount of receivables written off | (144) | (286) |
Foreign currency translation and other | (32) | (186) |
Balance at end of period | $ 7,077 | $ 5,782 |
Inventories (Details)
Inventories (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Inventory Disclosure [Abstract] | ||
Raw materials and supplies | $ 73,080 | $ 74,302 |
Work-in-process | 25,077 | 22,913 |
Finished goods | 232,008 | 260,467 |
Inventories | $ 330,165 | $ 357,682 |
Product Warranty (Details)
Product Warranty (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Activity for accrued warranty expense | ||
Balance at beginning of period | $ 3,831 | $ 4,048 |
Provision | 1,029 | 1,209 |
Claims paid/costs incurred | (918) | (944) |
Foreign currency translation and other | (43) | (164) |
Balance at end of period | $ 3,899 | $ 4,149 |
Minimum | ||
Product Warranty Liability [Line Items] | ||
Product warranty period | 1 year | |
Maximum | ||
Product Warranty Liability [Line Items] | ||
Product warranty period | 2 years |
Debt and Financing Arrangemen_2
Debt and Financing Arrangements (Details) | Jul. 03, 2020 | Mar. 31, 2021USD ($) | Dec. 31, 2020USD ($) |
Unsecured local credit facilities | |||
Line of Credit Facility [Line Items] | |||
Weighted average interest rate | 0.28% | 2.00% | |
Available borrowings | $ 50,300,000 | ||
Other short-term borrowings, outstanding borrowings | 8,800,000 | $ 2,800,000 | |
Revolving Credit Facility | |||
Line of Credit Facility [Line Items] | |||
Outstanding borrowings | $ 15,900,000 | 0 | |
Weighted average interest rate | 1.79% | ||
Available borrowings | $ 376,000,000 | ||
Letters of credit outstanding | 8,100,000 | ||
Unamortized fees and expenses | 700,000 | ||
Revolving Credit Facility | Minimum | |||
Line of Credit Facility [Line Items] | |||
Leverage ratio basis spread | 0.15% | ||
Revolving Credit Facility | Maximum | |||
Line of Credit Facility [Line Items] | |||
Leverage ratio basis spread | 0.30% | ||
Letters of Credit | |||
Line of Credit Facility [Line Items] | |||
Outstanding borrowings | 11,800,000 | 11,700,000 | |
Line of credit secured | 8,600,000 | $ 8,300,000 | |
Maximum commitment | $ 53,700,000 | ||
Bridge Loan | Fed Funds Effective Rate Overnight Index Swap Rate | |||
Line of Credit Facility [Line Items] | |||
Variable rate of interest | 0.50% | ||
Line of Credit | |||
Line of Credit Facility [Line Items] | |||
Initial commitment fee rate | 0.20% | ||
Secured leverage ratio | 3.50 | ||
Increase in leverage ratio | 3.75 | ||
Interest coverage ratio | 3 | ||
Line of Credit | Minimum | |||
Line of Credit Facility [Line Items] | |||
Variable rate of interest | 0.00% | ||
Line of Credit | Maximum | |||
Line of Credit Facility [Line Items] | |||
Variable rate of interest | 0.75% | ||
Line of Credit | Canadian Dollar Offered Rate Cdor | |||
Line of Credit Facility [Line Items] | |||
Variable rate of interest | 1.00% | ||
Line of Credit | Canadian Dollar Offered Rate Cdor | Minimum | |||
Line of Credit Facility [Line Items] | |||
Leverage ratio basis spread | 1.00% | ||
Line of Credit | Canadian Dollar Offered Rate Cdor | Maximum | |||
Line of Credit Facility [Line Items] | |||
Leverage ratio basis spread | 1.75% |
Derivative Instruments and Hedg
Derivative Instruments and Hedging Activities - Narrative (Details) | 3 Months Ended | |
Mar. 31, 2021USD ($)derivative | Dec. 31, 2020USD ($)derivative | |
Foreign exchange forward | ||
Derivatives, Fair Value [Line Items] | ||
Expected reclassification of gain (loss) recorded in accumulated other comprehensive loss, net of tax into cost of goods sold during next twelve months | $ (3,200,000) | |
Foreign exchange forward | Derivative designated as hedging | ||
Derivatives, Fair Value [Line Items] | ||
Notional amount | 219,000,000 | $ 248,100,000 |
Foreign exchange forward | Not Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Notional amount of hedges deemed ineffective | $ 0 | $ 0 |
Number of outstanding contracts | derivative | 0 | 0 |
Foreign exchange forward | Maximum | ||
Derivatives, Fair Value [Line Items] | ||
Term of derivative contract | 24 months | |
Interest rate swap | ||
Derivatives, Fair Value [Line Items] | ||
Expected reclassification of gain (loss) recorded in accumulated other comprehensive loss, net of tax into cost of goods sold during next twelve months | $ (600,000) | |
Interest rate swap | Derivative designated as hedging | ||
Derivatives, Fair Value [Line Items] | ||
Notional amount | $ 140,000,000 | $ 140,000,000 |
Derivative Financial Instrume_3
Derivative Financial Instruments - Fair Value of Hedge Instruments in Unaudited Condensed Consolidated Balance Sheets (Details) - Derivative Designated as Hedging - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Foreign exchange forward | Prepaid and other assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset derivatives | $ 3,476 | $ 1,166 |
Foreign exchange forward | Other assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset derivatives | 1,225 | 30 |
Foreign exchange forward | Accrued expenses and other liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability derivatives | 3,929 | 6,400 |
Foreign exchange forward | Other noncurrent liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability derivatives | 92 | 985 |
Interest rate swap | Accrued expenses and other liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability derivatives | $ 621 | $ 1,571 |
Derivative Instruments and He_2
Derivative Instruments and Hedging Activities - Effect of Hedge Instruments in Unaudited Condensed Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||
Unrealized holding gains arising during period | $ 4,367 | $ 7,402 |
Cash flow hedge | Derivative designated as hedging | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Unrealized holding gains arising during period | 4,367 | 7,402 |
Foreign exchange forward | Cash flow hedge | Derivative designated as hedging | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Unrealized holding gains arising during period | 4,376 | 9,467 |
Interest rate swap | Cash flow hedge | Derivative designated as hedging | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Unrealized holding gains arising during period | $ (9) | $ (2,065) |
Derivative Financial Instrume_4
Derivative Financial Instruments - Effect of Hedge Instruments in Unaudited Condensed Comprehensive Income (Loss) And Statement of Operations (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||
Net gain reclassified out of accumulated other comprehensive loss, net of tax related to hedges deemed ineffective | $ (563) | $ 1,724 |
Derivative designated as hedging | Foreign exchange forward | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized on unaudited condensed consolidated statements of operations | 1,036 | 3,076 |
Derivative designated as hedging | Foreign exchange forward | Cost of goods sold | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized on unaudited condensed consolidated statements of operations | 396 | 1,542 |
Derivative designated as hedging | Foreign exchange forward | Selling, general and administrative | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized on unaudited condensed consolidated statements of operations | 640 | 1,534 |
Net gain reclassified out of accumulated other comprehensive loss, net of tax related to hedges deemed ineffective | 700 | |
Derivative designated as hedging | Interest rate swap | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized on unaudited condensed consolidated statements of operations | (959) | (478) |
Derivative designated as hedging | Interest rate swap | Interest expense, net | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized on unaudited condensed consolidated statements of operations | $ (959) | $ (478) |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Level 1 | ||
Assets | ||
Total assets | $ 5,849 | $ 5,962 |
Liabilities | ||
Total liabilities | 803 | 802 |
Level 2 | ||
Assets | ||
Total assets | 4,701 | 1,196 |
Liabilities | ||
Total liabilities | 4,642 | 8,956 |
Level 3 | ||
Assets | ||
Total assets | 0 | 0 |
Liabilities | ||
Total liabilities | 0 | 0 |
Prepaid and other assets | Level 1 | ||
Assets | ||
Rabbi trust | 5,046 | 5,160 |
Prepaid and other assets | Level 2 | ||
Assets | ||
Rabbi trust | 0 | 0 |
Prepaid and other assets | Level 3 | ||
Assets | ||
Rabbi trust | 0 | 0 |
Prepaid and other assets | Foreign exchange derivative instruments | Level 1 | ||
Assets | ||
Derivative instruments | 0 | 0 |
Prepaid and other assets | Foreign exchange derivative instruments | Level 2 | ||
Assets | ||
Derivative instruments | 3,476 | 1,166 |
Prepaid and other assets | Foreign exchange derivative instruments | Level 3 | ||
Assets | ||
Derivative instruments | 0 | 0 |
Other assets | Level 1 | ||
Assets | ||
Deferred compensation program assets | 803 | 802 |
Other assets | Level 2 | ||
Assets | ||
Deferred compensation program assets | 0 | 0 |
Other assets | Level 3 | ||
Assets | ||
Deferred compensation program assets | 0 | 0 |
Other assets | Foreign exchange derivative instruments | Level 1 | ||
Assets | ||
Derivative instruments | 0 | 0 |
Other assets | Foreign exchange derivative instruments | Level 2 | ||
Assets | ||
Derivative instruments | 1,225 | 30 |
Other assets | Foreign exchange derivative instruments | Level 3 | ||
Assets | ||
Derivative instruments | 0 | 0 |
Accrued expenses and other liabilities | Foreign exchange derivative instruments | Level 1 | ||
Liabilities | ||
Derivative instruments | 0 | 0 |
Accrued expenses and other liabilities | Foreign exchange derivative instruments | Level 2 | ||
Liabilities | ||
Derivative instruments | 3,929 | 6,400 |
Accrued expenses and other liabilities | Foreign exchange derivative instruments | Level 3 | ||
Liabilities | ||
Derivative instruments | 0 | 0 |
Accrued expenses and other liabilities | Interest rate derivative instruments | Level 1 | ||
Liabilities | ||
Derivative instruments | 0 | 0 |
Accrued expenses and other liabilities | Interest rate derivative instruments | Level 2 | ||
Liabilities | ||
Derivative instruments | 621 | 1,571 |
Accrued expenses and other liabilities | Interest rate derivative instruments | Level 3 | ||
Liabilities | ||
Derivative instruments | 0 | 0 |
Other noncurrent liabilities | Level 1 | ||
Liabilities | ||
Deferred compensation program liabilities | 803 | 802 |
Other noncurrent liabilities | Level 2 | ||
Liabilities | ||
Deferred compensation program liabilities | 0 | 0 |
Other noncurrent liabilities | Level 3 | ||
Liabilities | ||
Deferred compensation program liabilities | 0 | 0 |
Other noncurrent liabilities | Foreign exchange derivative instruments | Level 1 | ||
Liabilities | ||
Derivative instruments | 0 | 0 |
Other noncurrent liabilities | Foreign exchange derivative instruments | Level 2 | ||
Liabilities | ||
Derivative instruments | 92 | 985 |
Other noncurrent liabilities | Foreign exchange derivative instruments | Level 3 | ||
Liabilities | ||
Derivative instruments | $ 0 | $ 0 |
Pension and Other Postretirem_3
Pension and Other Postretirement Benefits (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Pension Benefits | ||
Components of net periodic benefit cost | ||
Service cost | $ 2,135 | $ 2,316 |
Interest cost | 1,951 | 2,512 |
Expected return on plan assets | (2,547) | (2,903) |
Settlement expense | 1,419 | 0 |
Amortization of net loss (gain) | 1,421 | 964 |
Amortization of prior service cost (credit) | 71 | 70 |
Net periodic benefit cost | 4,450 | 2,959 |
Postretirement Benefits | ||
Components of net periodic benefit cost | ||
Service cost | 162 | 171 |
Interest cost | 75 | 112 |
Expected return on plan assets | 0 | 0 |
Settlement expense | 0 | 0 |
Amortization of net loss (gain) | (65) | (214) |
Amortization of prior service cost (credit) | (34) | (34) |
Net periodic benefit cost | $ 138 | $ 35 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Income Tax Disclosure [Abstract] | ||
Increase (decrease) in income tax expense | $ 20,200 | |
Income tax expense | $ 27,834 | $ 7,640 |
Effective tax rate | 24.30% | 46.00% |
Common Stock - Dividends and Sh
Common Stock - Dividends and Share Repurchase Program (Details) - USD ($) | Apr. 02, 2021 | Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2020 | May 06, 2021 |
Equity [Abstract] | ||||||||
Dividends per Common Share (in dollars per share) | $ 0.165 | $ 0.155 | $ 0.155 | $ 0.155 | $ 0.155 | $ 0.620 | ||
Amount | $ 12,767,000 | $ 11,983,000 | $ 11,790,000 | $ 11,761,000 | $ 11,735,000 | $ 47,269,000 | ||
Dividends Payable [Line Items] | ||||||||
Issued and outstanding common stock authorized to repurchase | $ 100,000,000 | |||||||
Accrued share repurchase (in shares) | 355,341 | 299,894 | 299,894 | |||||
Amount remaining under current authorizations | $ 61,300,000 | |||||||
Aggregate value | 2,377,000 | $ 6,976,000 | ||||||
Subsequent Event | ||||||||
Dividends Payable [Line Items] | ||||||||
Dividends declared and payable (in dollars per share) | $ 0.165 | |||||||
Magnus | ||||||||
Dividends Payable [Line Items] | ||||||||
Stock repurchase program, authorized amount | 24,900,000 | |||||||
Share repurchase liability | $ 11,100,000 | $ 8,800,000 | $ 8,800,000 | |||||
Accrued share repurchase (in shares) | 355,341 | 299,894 | 299,894 | |||||
Amount remaining under current authorizations | $ 11,100,000 | |||||||
Aggregate purchases of shares in open market before shares will be purchased from Magnus | $ 24,900,000 | |||||||
Magnus | Subsequent Event | ||||||||
Dividends Payable [Line Items] | ||||||||
Shares repurchased (in shares) | 355,341 | |||||||
Aggregate value | $ 11,100,000 |
Common Stock - Schedule of Shar
Common Stock - Schedule of Share Repurchase Activity (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Dividends Payable [Line Items] | ||
Aggregate value | $ 2,377 | $ 6,976 |
Open Market | ||
Dividends Payable [Line Items] | ||
Shares repurchased (in shares) | 56,156 | 243,894 |
Average price (in dollars per share) | $ 42.34 | $ 28.60 |
Aggregate value | $ 2,377 | $ 6,976 |
Equity Incentive Plans - Narrat
Equity Incentive Plans - Narrative (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2021USD ($) | |
RSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized compensation expense | $ 23.4 |
Weighted average period | 2 years 3 months 18 days |
PSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period | 3 years |
Unrecognized compensation expense | $ 13 |
Weighted average period | 2 years 2 months 12 days |
Minimum | PSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting percentage | 0.00% |
Maximum | PSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting percentage | 200.00% |
Company officers | RSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period | 3 years |
Vesting percentage | 33.33% |
Officers, employees, consultants and advisors | RSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting period | 3 years |
Equity Incentive Plans - Restri
Equity Incentive Plans - Restricted Stock and Performance Stock Units (Details) - 2015 Omnibus Incentive Plan | 3 Months Ended |
Mar. 31, 2021$ / sharesshares | |
RSUs | |
Number of Units | |
Outstanding at beginning of the period (in shares) | 1,253,173 |
Granted (in shares) | 289,259 |
Vested (in shares) | (362,605) |
Forfeited (in shares) | (20,290) |
Outstanding at end of the period (in shares) | 1,159,537 |
Weighted - Average Fair Value | |
Outstanding at beginning of the period (in dollars per share) | $ / shares | $ 24.33 |
Granted (in dollars per share) | $ / shares | 45.36 |
Vested (in dollars per share) | $ / shares | 24.11 |
Forfeited (in dollars per share) | $ / shares | 24.24 |
Outstanding at end of the period (in dollars per share) | $ / shares | $ 29.65 |
Undelivered (in shares) | 110,514 |
PSUs | |
Number of Units | |
Outstanding at beginning of the period (in shares) | 457,576 |
Granted (in shares) | 145,110 |
Vested (in shares) | 0 |
Forfeited (in shares) | (2,631) |
Outstanding at end of the period (in shares) | 600,055 |
Weighted - Average Fair Value | |
Outstanding at beginning of the period (in dollars per share) | $ / shares | $ 24.55 |
Granted (in dollars per share) | $ / shares | 45.36 |
Vested (in dollars per share) | $ / shares | 0 |
Forfeited (in dollars per share) | $ / shares | 25.45 |
Outstanding at end of the period (in dollars per share) | $ / shares | $ 29.58 |
Undelivered (in shares) | 0 |
Equity Incentive Plans - Summar
Equity Incentive Plans - Summary of Shares of Common Stock Issued (Details) - 2015 Omnibus Incentive Plan - shares | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
RSUs | ||
Class of Stock [Line Items] | ||
Cumulative undelivered shares of common stock (in shares) | 110,514 | |
PSUs | ||
Class of Stock [Line Items] | ||
Cumulative undelivered shares of common stock (in shares) | 0 | |
Common Stock | RSUs | ||
Class of Stock [Line Items] | ||
Shares of common stock issued (in shares) | 270,779 | 42,797 |
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares) | (89,938) | (13,831) |
Net shares of common stock issued (in shares) | 180,841 | 28,966 |
Cumulative undelivered shares of common stock (in shares) | 395,670 | 240,512 |
Common Stock | PSUs | ||
Class of Stock [Line Items] | ||
Shares of common stock issued (in shares) | 0 | 0 |
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares) | 0 | 0 |
Net shares of common stock issued (in shares) | 0 | 0 |
Cumulative undelivered shares of common stock (in shares) | 0 | 0 |
Equity Incentive Plans - Compen
Equity Incentive Plans - Compensation Expense Recorded in the Consolidated Statement of Operations (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Compensation expense | $ 5,533 | $ 2,187 |
RSUs | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Compensation expense | 2,359 | 2,478 |
PSUs | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Compensation expense | $ 3,010 | $ (455) |
Equity Incentive Plans - Alloca
Equity Incentive Plans - Allocation of Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total compensation expense before income tax | $ 5,533 | $ 2,187 |
Income tax benefit | 1,267 | 463 |
Total compensation expense, net of income tax | 4,266 | 1,724 |
Cost of goods sold | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total compensation expense before income tax | (7) | 225 |
Selling, general and administrative | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total compensation expense before income tax | 5,381 | 1,714 |
Research and development | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total compensation expense before income tax | $ 159 | $ 248 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Loss, Net of Tax (Details) $ in Thousands | 3 Months Ended |
Mar. 31, 2021USD ($) | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | $ 1,017,253 |
Other comprehensive income (loss) before reclassifications | (2,950) |
Amounts reclassified from accumulated other comprehensive loss, net of tax | 3,375 |
Tax expense | (2,403) |
Ending balance | 1,085,980 |
Foreign Currency Translation Adjustments | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | (43,906) |
Other comprehensive income (loss) before reclassifications | (7,080) |
Amounts reclassified from accumulated other comprehensive loss, net of tax | 0 |
Tax expense | 0 |
Ending balance | (50,986) |
Gains (Losses) on Derivative Instruments | Foreign Exchange Derivative Instruments | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | (4,471) |
Other comprehensive income (loss) before reclassifications | 4,376 |
Amounts reclassified from accumulated other comprehensive loss, net of tax | (396) |
Tax expense | (1,435) |
Ending balance | (1,926) |
Gains (Losses) on Derivative Instruments | Interest Rate Swap Derivative Instruments | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | (1,179) |
Other comprehensive income (loss) before reclassifications | (9) |
Amounts reclassified from accumulated other comprehensive loss, net of tax | 959 |
Tax expense | (229) |
Ending balance | (458) |
Pension and Other Postretirement Adjustments | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | (46,626) |
Other comprehensive income (loss) before reclassifications | (237) |
Amounts reclassified from accumulated other comprehensive loss, net of tax | 2,812 |
Tax expense | (739) |
Ending balance | (44,790) |
Accumulated Other Comprehensive Loss, Net of Tax | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
Beginning balance | (96,182) |
Ending balance | $ (98,160) |
Net Income per Common Share - C
Net Income per Common Share - Computation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Earnings Per Share [Abstract] | ||
Net income attributable to Acushnet Holdings Corp. | $ 84,958 | $ 8,877 |
Weighted average number of common shares: | ||
Basic (in shares) | 74,778,189 | 74,545,280 |
Diluted (in shares) | 75,255,312 | 75,099,930 |
Net income per common share attributable to Acushnet Holdings Corp.: | ||
Basic (in dollars per share) | $ 1.14 | $ 0.12 |
Diluted (in dollars per share) | $ 1.13 | $ 0.12 |
Net Income per Common Share -_2
Net Income per Common Share - Calculation of Diluted Weighted Average Common Shares Outstanding (Details) - shares | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
RSUs | ||
Securities excluded from calculation of diluted weighted-average common shares outstanding as their impact was anti-dilutive (in shares) | 291,484 | 0 |
Segment Information - Reconcili
Segment Information - Reconciliation (Details) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021USD ($)segment | Mar. 31, 2020USD ($) | |
Segment Reporting [Abstract] | ||
Number of reportable segments | segment | 4 | |
Segment Reporting Information [Line Items] | ||
Total net sales | $ 580,885 | $ 408,741 |
Segment operating income | 120,069 | 21,428 |
Reconciling items: | ||
Interest expense, net | (3,616) | (4,123) |
Restructuring charges | 0 | (11,628) |
Income before income taxes | 114,461 | 16,615 |
Other | ||
Segment Reporting Information [Line Items] | ||
Total net sales | 38,867 | 25,376 |
Segment operating income | 6,471 | 1,080 |
Operating segments and other | ||
Segment Reporting Information [Line Items] | ||
Segment operating income | 120,432 | 31,988 |
Reconciling Items | ||
Reconciling items: | ||
Interest expense, net | (3,616) | (4,123) |
Restructuring charges | 0 | (11,628) |
Non-service cost component of net periodic benefit cost | (2,291) | (507) |
Other | (64) | 885 |
Titleist golf balls | Operating segments | ||
Segment Reporting Information [Line Items] | ||
Total net sales | 173,637 | 116,239 |
Segment operating income | 34,317 | 3,243 |
Titleist golf clubs | Operating segments | ||
Segment Reporting Information [Line Items] | ||
Total net sales | 155,827 | 93,214 |
Segment operating income | 41,799 | 4,503 |
Titleist golf gear | Operating segments | ||
Segment Reporting Information [Line Items] | ||
Total net sales | 53,120 | 43,525 |
Segment operating income | 9,728 | 8,865 |
FootJoy golf wear | Operating segments | ||
Segment Reporting Information [Line Items] | ||
Total net sales | 159,434 | 130,387 |
Segment operating income | $ 28,117 | $ 14,297 |
Segment Information - Geographi
Segment Information - Geographical Areas (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total net sales | $ 580,885 | $ 408,741 |
United States | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total net sales | 308,636 | 211,008 |
EMEA | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total net sales | 80,575 | 74,671 |
Japan | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total net sales | 56,377 | 37,556 |
Korea | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total net sales | 79,097 | 50,449 |
Rest of world | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total net sales | $ 56,200 | $ 35,057 |
Commitments and Contingencies -
Commitments and Contingencies - Purchase Commitments (Details) $ in Thousands | Mar. 31, 2021USD ($) |
Payments Due by Period | |
Remainder of 2021 | $ 200,097 |
2022 | 16,026 |
2023 | 3,282 |
2024 | 2,545 |
2025 | 2,549 |
Thereafter | $ 1,284 |
Restructuring Charges - Additio
Restructuring Charges - Additional Information (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Restructuring Cost and Reserve [Line Items] | ||
Restructuring charges | $ 0 | $ 11,628,000 |
Restructuring and related costs expected | $ 0 | |
VBR | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring costs incurred to date | 11,200,000 | |
Restructuring charges | 11,200,000 | |
Other restructuring program | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring costs incurred to date | 2,000,000 | |
Restructuring charges | $ 400,000 |
Restructuring Charges - Schedul
Restructuring Charges - Schedule of Company's Restructuring Program Rollforward (Details) $ in Thousands | 3 Months Ended |
Mar. 31, 2021USD ($) | |
VBR | |
Restructuring Reserve [Roll Forward] | |
Balance at beginning of period | $ 6,243 |
Payments | (2,161) |
Foreign currency translation and other | 0 |
Balance at end of period | 4,082 |
Other | |
Restructuring Reserve [Roll Forward] | |
Balance at beginning of period | 778 |
Payments | (565) |
Foreign currency translation and other | (1) |
Balance at end of period | $ 212 |
Restructuring Charges - Restruc
Restructuring Charges - Restructuring Liabilities Recognized on Balance Sheet (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
VBR | Accrued compensation and benefits | ||
Restructuring Cost and Reserve [Line Items] | ||
Accrued compensation and benefits | $ 4,039 | $ 6,018 |
VBR | Other noncurrent liabilities | ||
Restructuring Cost and Reserve [Line Items] | ||
Other noncurrent liabilities | 43 | 225 |
Other | Accrued compensation and benefits | ||
Restructuring Cost and Reserve [Line Items] | ||
Accrued compensation and benefits | $ 212 | $ 778 |